LENZ Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.18	20.16	35.14	47.73	376.98
Short-Term Investments	267.17	188.87	30.65	220.5	-
Cash & Short-Term Investments	292.35	209.03	65.79	268.23	376.98
Cash Growth	39.86%	217.70%	-75.47%	-28.85%	1805.65%
Accounts Receivable	0.33	-	-	-	-
Inventory	2.94	-	-	-	-
Other Current Assets	5.8	2.89	1.45	7.14	4.76
Total Current Assets	301.41	211.92	67.24	275.37	381.74
Net Property, Plant & Equipment	1.92	1.99	0.37	28.21	18.08
Long-Term Investments	-	-	-	15.32	-
Other Long-Term Assets	2.54	1.4	2.76	3.01	2.17
Total Assets	305.88	215.3	70.38	321.9	401.99
Accounts Payable	4.17	4.26	5.71	2.61	2.45
Accrued Expenses	17.02	6.15	12.8	6.39	4.21
Current Portion of Leases	-	-	-	4.05	5.48
Total Current Liabilities	21.19	10.41	18.51	13.04	12.14
Long-Term Leases	0.35	0.81	0.19	1.75	5.79
Other Long-Term Liabilities	-	-	0.99	10.82	-
Total Long-Term Liabilities	0.35	0.81	1.18	12.57	5.79
Total Liabilities	21.54	11.22	19.7	25.61	17.94
Common Stock	0	0	5.91	0	0
Additional Paid-in Capital	511.24	348.9	2.52	539.74	525.4
Accumulated Other Comprehensive Income	0.24	0.2	0.01	-1.05	-
Retained Earnings	-227.14	-145.01	-95.25	-242.4	-141.35
Total Common Shareholders' Equity	284.34	204.08	-86.81	296.29	384.05
Minority Interest	-	-	137.49	-	-
Shareholders' Equity	284.34	204.08	50.68	296.29	384.05
Total Liabilities & Equity	305.88	215.3	70.38	321.9	401.99
Total Debt	0.35	0.81	0.19	5.79	11.28
Net Cash (Debt)	292	208.22	65.6	262.44	365.7
Net Cash Growth	40.24%	217.39%	-75.00%	-28.24%	1748.65%
Net Cash Per Share	10.13	9.78	15.88	63.52	88.52
Book Value	284.34	204.08	-86.81	296.29	384.05
Book Value Per Share	9.87	9.59	-21.01	71.72	92.96
Tangible Book Value	284.34	204.08	-86.81	296.29	384.05
Tangible Book Value Per Share	9.87	9.59	-21.01	71.72	92.96

Updated Mar 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q